Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hypertension, Portal

• A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly
• NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients
• TIPS Plus Cadonilimab in Advanced HCC With Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study
• Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.
• LiveSMART Trial to Prevent Falls in Patients With Cirrhosis
• Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.
• Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding
• The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot Study
• Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial
• Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
• Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection
• A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to th
• Vonoprazan Efficacy to Prevent Post Variceal Band Ligation Ulcer
• A Study to Test Whether Two Different Doses of BI 685509 Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)
• Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
• Extension Study of Carvedilol RCT Study
• Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension
• Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal Hypertension
• SHAPE of Portal Hypertension in Children
• EUS-guided PSE in Combination With EUS-guided Treatment of Varices for Patients With Portal Hypertension
• Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）
• Primary Prophylaxis for Variceal Bleed in Biliary Atresia
• Anticoagulation Therapy After Splenectomy in Cirrhosis Patient
• Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.
• Ivabradine in Cirrhotic Cardiomyopathy
• Somatostatin in Living Donor Liver Transplantation
• Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
• The Role of Somatostatin in the Hemodynamics of the Hepatic Circulation in Patients Undergoing Liver Resection
• Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension
• A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis
• HVPG-guided Laparoscopic Versus Endoscopic Therapy for Variceal Rebleeding in Portal Hypertension: A Multicenter Randomized Controlled Trial (CHESS1803)
• Carvedilol for Prevention of Esophageal Varices Progression
• Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension
• Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14
• PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)
• The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices
• Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction
• Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis
• 8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding in Patients With Child A Cirrhosis
• Evaluation Of The Portal Pressure By Doppler Ultrasound In Cirrhotic Patients Before And After Simvastatin
• Doppler Ultrasound Hepatic Vein Waveform as a Non-invasive Tool in the Assessment of Severity of Portal Hypertension
• Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension
• Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Fuzheng Huayu and Entecavir
• Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir
• A Study to Investigate the Safety and Effect of the Study Drug (FE 204205) in Patients With Cirrhotic Portal Hypertension
• Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPS
• Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis
• TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV
• Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients
• Serelaxin To Lower Portal Pressure
• Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices
• Surrogate Markers of Portal Pressure
• Cavernous Transformation of Portal Vein： Etiology, Diagnosis, Management and Prognosis
• Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension
• 3D CT Guidance for Transjugular Intrahepatic Portosystemic Shunt Creation
• 8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding
• To Compare the Efficacy and Safety of Carvedilol With or Without Simvastatin in Patients With Portal Hypertension and Esophageal Varices.
• Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
• Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis
• A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
• Simvastatin Effect on Portal Hypertension
• Carvedilol vs Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding
• Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric Varices
• Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients
• Quality of Life and Nutritional Improvements in Cirrhotic Patients
• The Effect of Sorafenib on Portal Pressure
• Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation
• An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension
• Probiotics for Liver Cirrhosis With Portal Hypertension
• Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension
• The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS
• Evaluation of Efficacy and Safety of Somatostatin Used as Inflow Modulator in Liver Transplantation.
• Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis
• Hemodynamic Effect of Simvastatin With Beta Blockers in Clinical Portal Hypertension
• A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding
• Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
• Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy
• Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding
• RCT of Carvedilol Versus Variceal Band Ligation in the Primary Prophylaxis of Oesophageal Variceal Haemorrhage
• Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
• The Effect of Probiotics (VSL) on Portal Hypertension
• Comparison of Endoscopic Variceal Ligation (EVL) With Propranolol in Non Cirrhotic Portal Hypertension (NCPH)
• Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE
• Endoscopic Variceal Ligation (EVL)+ Drugs Versus Endoscopic Variceal Ligation (EVL) Alone For Secondary Prophylaxis
• Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
• Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension
• Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis
• The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed
• Danish Carvedilol Study in Portal Hypertension
• Secondary Prophylaxis After Variceal Bleeding in Non-Responders
• Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure
• Short Course Terlipressin for Control of Acute Variceal Bleeding
• Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis
• Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
• Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C
• Vasoactive Peptides in Portal Pressure
• Prevention of Esophageal Varices by Beta-Adrenergic Blockers
• Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis
• Prevention of Esophageal Varices by Beta-Adrenergic Blockers